Solvay/€SOLB

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Solvay

Solvay SA, listed under ticker SOLB, is a Belgium-based international chemical and advanced materials company. It operates through several business segments including Advanced Materials, Advanced Formulations, Performance Chemicals, and Corporate & Business Services. The company was founded in 1863 and has established itself as a key player in producing a wide range of products used in applications such as automotive, electronics, and healthcare.

Ticker

€SOLB
Sector

Primary listing

BSE

Employees

9,000

Solvay Metrics

BasicAdvanced
€2.9B
21.23
€1.31
0.67
€1.70
6.14%

What the Analysts think about Solvay

Analyst ratings (Buy, Hold, Sell) for Solvay stock.

Bulls say / Bears say

Solvay announced the expansion of its La Rochelle rare earth processing plant to produce neodymium and praseodymium, targeting 30% of Europe’s demand by 2030 and positioning the company to capitalize on growing EV and wind turbine markets (Reuters)
In Q2 2025, Solvay delivered €29 million in structural cost savings, bringing cumulative savings to €165 million since 2024 and ensuring the company remains on track to exceed its €200 million cost savings target by year-end (Solvay Q2 2025 Results turn1search0)
Despite a challenging market, Solvay maintained a robust underlying EBITDA margin of 20.9% in Q2 2025, underscoring strong pricing power and disciplined cost management amid currency headwinds (Solvay Q2 2025 Results turn1search0)
Solvay has cut its full-year 2025 underlying EBITDA guidance to €880–€930 million from a prior €1.0–€1.1 billion range, signaling more cautious growth expectations amid ongoing market headwinds (Reuters)
Organic Q2 2025 revenues fell 3.8% year-on-year to €1,102 million and underlying EBITDA declined 12.4% organically, reflecting persistent demand softness across key end markets (Solvay Q2 2025 Results turn1search0)
Underlying net debt reached €1.9 billion in Q2 2025, translating to a leverage ratio of 1.9x, which could constrain financial flexibility and elevate credit risk (Solvay Q2 2025 Results turn1search0)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.

Solvay Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Solvay Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SOLB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs